The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: A multicenter, open-label, single-arm phase 2 study.
 
Lili Mao
Honoraria - MSD; Novartis; Shanghai Junshi BioSciences
Research Funding - MSD
 
Meiyu Fang
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Xue Bai
Other Relationship - Bristol-Myers Squibb
 
Jun Cao
No Relationships to Disclose
 
Jing Lin
No Relationships to Disclose
 
Peng Zhang
No Relationships to Disclose
 
Ling Chen
No Relationships to Disclose
 
Jiahui Xu
Employment - Shanghai Roche Pharmaceuticals
 
Jun Guo
Consulting or Advisory Role - Bayer; MSD; Novartis; Oriengene; Pfizer; Roche; Shanghai Junshi BioSciences; Simcere
 
Lu Si
Honoraria - MSD; Novartis; Oriengene; Roche China; Shanghai Junshi Biosciences